Thermo Fisher Scientific Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Apr 2017 | $24.42B | $46.21B | $713.3M |
| Jul 2017 | $24.12B | $46.51B | $611.0M |
| Sep 2017 | $31.28B | $55.99B | $741.1M |
| Dec 2017 | $31.26B | $56.67B | $1.34B |
| Mar 2018 | $30.46B | $56.58B | $950.0M |
| Jun 2018 | $28.96B | $55.40B | $937.0M |
| Sep 2018 | $28.19B | $55.08B | $1.10B |
| Dec 2018 | $28.65B | $56.23B | $2.10B |
| Mar 2019 | $27.90B | $55.60B | $1.11B |
| Jun 2019 | $29.24B | $57.97B | $2.29B |
| Sep 2019 | $27.37B | $56.73B | $1.27B |
| Dec 2019 | $28.71B | $58.38B | $2.40B |
| Mar 2020 | $30.13B | $58.69B | $2.98B |
| Jun 2020 | $31.72B | $61.59B | $5.82B |
| Sep 2020 | $32.24B | $64.06B | $7.54B |
| Dec 2020 | $34.55B | $69.05B | $10.33B |
| Apr 2021 | $30.87B | $65.93B | $5.58B |
| Jul 2021 | $30.84B | $67.70B | $7.02B |
| Oct 2021 | $34.89B | $73.60B | $12.03B |
| Dec 2021 | $54.33B | $95.12B | $4.48B |
| Apr 2022 | $51.79B | $92.75B | $2.75B |
| Jul 2022 | $48.29B | $90.58B | $1.89B |
| Oct 2022 | $46.99B | $90.54B | $2.92B |
| Dec 2022 | $53.18B | $97.15B | $8.52B |
| Apr 2023 | $52.40B | $94.66B | $3.48B |
| Jul 2023 | $50.35B | $94.11B | $3.13B |
| Sep 2023 | $51.73B | $97.06B | $6.15B |
| Dec 2023 | $51.99B | $98.73B | $8.08B |
| Mar 2024 | $51.58B | $97.10B | $5.50B |
| Jun 2024 | $51.06B | $98.50B | $7.07B |
| Sep 2024 | $51.37B | $100.36B | $4.65B |
| Dec 2024 | $47.74B | $97.32B | $4.01B |
| Mar 2025 | $49.65B | $99.04B | $4.13B |
| Jun 2025 | $50.72B | $101.23B | $4.58B |
| Sep 2025 | $52.00B | $103.02B | $1.98B |
| Dec 2025 | $56.94B | $110.34B | $9.85B |
| Mar 2026 | $61.35B | $113.28B | $3.25B |
| Jun 2026 | $60.50B | $113.17B | $4.06B |